ABCG2 and colonic neoplasm: Particularly, ABC transporters can actively expel intracellular chemotherapeutic drugs, including oxaliplatin, significantly reducing their efficacy, while the overexpression of Bcl-2 was shown to protect colon cancer cells from chemotherapy-induced apoptosis, further promoting oxaliplatin resistance [40].